logo-loader
AIM:SKIN

Integumen

Receive alerts
Market:
AIM
Market Cap:
£10.72 m
Price
1.00 GBX
Change
0.00%
52 weeks high
2.55
52 weeks low
0.70

‘Our digital and physical team members, across all subsidiaries, continue to deliver consistent reliable revenue growth as we scale-up our new digital platform.’

Gerry Brandon, CEO Integumen

 

Labskin

Lab-grown, human skin, for testing cosmetic and pharma products for dandruff, acne, fungal and bacterial infection.

Innovenn Skin Science

Labskin Certification of products, and training of Lab technicians. Virtual Lab services for cosmetic, skincare and pharma companies.

Stoer Cosmetics

Skincare products derived from 5 natural super-ingredient plant extracts for men to reduce the signs of aging.

WoundPhase

Visual diagnostic wound dressing that changes colour to indicate infection or improvement of the wound under the dressing.

Micro Biomaterials

The design and fabrication of smart materials for studying, directing and mimicking biology.

Omega 3 from Algae

Major health benefits, an alternative production to extraction from declining global fish stocks.

Bio-Plastic Ingredients

Solution to dumping 8 million tonnes of waste plastic in the oceans each year. Alternative biodegradable plastic solution.

Algzym Technology

Low-cost, solvent-free, commercial scale production of Omega-3 oils from micro-algae and CBD oils from hemp.

Cellulac

Commercial License Partners of the Algzym Technology platform for bio-based oils, Omega 3, CBD and bio-plastic ingredients.

Senior Management 

Gerard Brandon

CEO

CEO of Cellulac. Founder and CEO of Alltracel Pharmaceuticals and Managing Partner at Farmabrand PE, Fellow of the Ryan Academy of Entrepreneurs

Camillus Glover

CFO

Former Operations Director at Campbell Bewley Group before becoming Chief of Operations at Alltracel Pharmaceuticals Member of the Institute of Chartered Accountants

Fionan Murray

COO

Founder of Rinocloud. Senior Executive in high growth software (SaaS) systems for Financial and Government Services, Global Biotech and Domestic Energy & Water Utilities

Paul Ryan

CSO

Former head of new business development at 8 West Consulting (clients including Estee Lauder, Avon, Anthem Inc.), experienced VP of international sales with partners such as Accenture, Siemens, SAP, Dell and Sony.

IT/AI/Tech

Colin O'Sullivan

CIO

Former Group Information Officer at the Australian Medical Association. Cross-platform software expertise in medical and science applications across enterprise, cloud computing, artificial intelligence and IT operations.

James O'Sullivan

CTO

James is an open-source developer and distributed systems advocate with a keen interest in engagement/collaboration platforms. A specialist in open-source technologies and advanced software architecture.

Jon Carroll

CMO

Talented results-driven digital marketing strategist with experience across a range of design led disciplines including UI/UX design, branding and web development. 15 years of experience in technology and design.

Science

Dr. David Callero

Lima Labskin

David joined the Integumen team as part of Labskin.

Alex Chapman

Labskin

Alex joined the Integumen team as part of Labskin.

IRELAND

12 St. James’s Terrace, Malahide, Dublin, K36N996, Ireland.

+44 (20) 3239 3716

[email protected]

UNITED KINGDOM

NAFIC, Sand Hutton, York, England, YO41 1LZ, United Kingdom.

+44 (0) 1904 40 4036

[email protected]

Significant Shareholders

As at 20 December 2019, shareholders holding more than 3% of the share capital of Integumen were:

Helium Rising Stars – 79,000,391 shares (7.37% of existing share capital)
Cellulac plc – 38,205,127 (3.56% of existing share capital)

Tel - +44 (20) 3239 3716

Email - [email protected]

Address

Sand Hutton Applied Innovation Campus,
Sand Hutton, York,
North Yorkshire YO41 1LZ,
United Kingdom